Modulating Tumoral Exosomes and Fibroblast Phenotype Using Nanoliposomes Augments Cancer Immunotherapy

Researchers showed that cancer cell–targeted nanoliposomes that inhibited sequential steps of exosome biogenesis and released from lung cancer cells block the differentiation of lung fibroblasts into cancer associated fibroblasts.